MAPT and Alzheimer disease: To investigate whether MSUT2 KO affects tau spreading, we enriched pathogenic tau seeds from AD postmortem brains (AD-tau) and injected them into the hippocampi of MSUT2 KO and wild-type mice at 3 months of age.